200 related articles for article (PubMed ID: 18407821)
21. Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues.
Heuzé Y; Singh N; Basilico C; Jabs EW; Holmes G; Richtsmeier JT
Bone; 2014 Jun; 63():101-9. PubMed ID: 24632501
[TBL] [Abstract][Full Text] [Related]
22. Maldevelopment of the submandibular gland in a mouse model of apert syndrome.
Yamaji K; Morita J; Watanabe T; Gunjigake K; Nakatomi M; Shiga M; Ono K; Moriyama K; Kawamoto T
Dev Dyn; 2018 Nov; 247(11):1175-1185. PubMed ID: 30251381
[TBL] [Abstract][Full Text] [Related]
23. Septal chondrocyte hypertrophy contributes to midface deformity in a mouse model of Apert syndrome.
Kim BS; Shin HR; Kim HJ; Yoon H; Cho YD; Choi KY; Choi JY; Kim WJ; Ryoo HM
Sci Rep; 2021 Apr; 11(1):7979. PubMed ID: 33846505
[TBL] [Abstract][Full Text] [Related]
24. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
25. FGF/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: evidence from Apert syndrome mouse models.
Martínez-Abadías N; Heuzé Y; Wang Y; Jabs EW; Aldridge K; Richtsmeier JT
PLoS One; 2011; 6(10):e26425. PubMed ID: 22053191
[TBL] [Abstract][Full Text] [Related]
26. A Ser252Trp substitution in mouse FGFR2 results in hyperplasia of embryonic salivary gland parenchyma.
Watanabe T; Kometani-Gunjigake K; Nakao-Kuroishi K; Ito-Sago M; Mizuhara M; Iwata D; Moriyama K; Ono K; Kawamoto T
J Oral Biosci; 2021 Jun; 63(2):184-191. PubMed ID: 33684522
[TBL] [Abstract][Full Text] [Related]
27. From shape to cells: mouse models reveal mechanisms altering palate development in Apert syndrome.
Martínez-Abadías N; Holmes G; Pankratz T; Wang Y; Zhou X; Jabs EW; Richtsmeier JT
Dis Model Mech; 2013 May; 6(3):768-79. PubMed ID: 23519026
[TBL] [Abstract][Full Text] [Related]
28. Exosome-mediated small interfering RNA delivery inhibits aberrant osteoblast differentiation in Apert syndrome model mice.
Myo AC; Kobayashi Y; Niki Y; Kamimoto H; Moriyama K
Arch Oral Biol; 2023 Sep; 153():105753. PubMed ID: 37348363
[TBL] [Abstract][Full Text] [Related]
29. FGFR2 mutation in a patient with Apert syndrome associated with humeroradial synostosis.
Kanauchi Y; Muragaki Y; Ogino T; Takahara M; Tsuchida H; Ishigaki D
Congenit Anom (Kyoto); 2003 Dec; 43(4):302-5. PubMed ID: 15041782
[TBL] [Abstract][Full Text] [Related]
30. S252W mutation in Indian patients of Apert syndrome.
Girisha KM; Phadke SR; Khan F; Agrawal S
Indian Pediatr; 2006 Aug; 43(8):733-5. PubMed ID: 16951439
[TBL] [Abstract][Full Text] [Related]
31. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.
Baroni T; Carinci P; Lilli C; Bellucci C; Aisa MC; Scapoli L; Volinia S; Carinci F; Pezzetti F; Calvitti M; Farina A; Conte C; Bodo M
J Cell Physiol; 2005 Feb; 202(2):524-35. PubMed ID: 15389579
[TBL] [Abstract][Full Text] [Related]
32. Cell Type-Dependent Nonspecific Fibroblast Growth Factor Signaling in Apert Syndrome.
Yeh E; Atique R; Fanganiello RD; Sunaga DY; Ishiy FA; Passos-Bueno MR
Stem Cells Dev; 2016 Aug; 25(16):1249-60. PubMed ID: 27339175
[TBL] [Abstract][Full Text] [Related]
33. Dynamic morphological changes in the skulls of mice mimicking human Apert syndrome resulting from gain-of-function mutation of FGFR2 (P253R).
Du X; Weng T; Sun Q; Su N; Chen Z; Qi H; Jin M; Yin L; He Q; Chen L
J Anat; 2010 Aug; 217(2):97-105. PubMed ID: 20557404
[TBL] [Abstract][Full Text] [Related]
34. [FGFR2 gene mutation in a Chinese patient with Apert syndrome].
Dai L; Li NN; Yuan YM; Liu Y; Zhu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Dec; 27(6):682-4. PubMed ID: 21154333
[TBL] [Abstract][Full Text] [Related]
35. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
Lemonnier J; Haÿ E; Delannoy P; Lomri A; Modrowski D; Caverzasio J; Marie PJ
J Bone Miner Res; 2001 May; 16(5):832-45. PubMed ID: 11341328
[TBL] [Abstract][Full Text] [Related]
36. Deformed Skull Morphology Is Caused by the Combined Effects of the Maldevelopment of Calvarias, Cranial Base and Brain in FGFR2-P253R Mice Mimicking Human Apert Syndrome.
Luo F; Xie Y; Xu W; Huang J; Zhou S; Wang Z; Luo X; Liu M; Chen L; Du X
Int J Biol Sci; 2017; 13(1):32-45. PubMed ID: 28123344
[TBL] [Abstract][Full Text] [Related]
37. Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis.
Miraoui H; Ringe J; Häupl T; Marie PJ
Hum Mol Genet; 2010 May; 19(9):1678-89. PubMed ID: 20124286
[TBL] [Abstract][Full Text] [Related]
38. Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth.
Martínez-Abadías N; Percival C; Aldridge K; Hill CA; Ryan T; Sirivunnabood S; Wang Y; Jabs EW; Richtsmeier JT
Dev Dyn; 2010 Nov; 239(11):3058-71. PubMed ID: 20842696
[TBL] [Abstract][Full Text] [Related]
39. Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology.
Holmes G; Rothschild G; Roy UB; Deng CX; Mansukhani A; Basilico C
Dev Biol; 2009 Apr; 328(2):273-84. PubMed ID: 19389359
[TBL] [Abstract][Full Text] [Related]
40. Genotype-Phenotype Correlation of Tracheal Cartilaginous Sleeves and Fgfr2 Mutations in Mice.
Lam AS; Liu CC; Deutsch GH; Rivera J; Perkins JA; Holmes G; Jabs EW; Cunningham ML; Dahl JP
Laryngoscope; 2021 Apr; 131(4):E1349-E1356. PubMed ID: 32886384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
